Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Current Taxes of $26.0 million for Q1 2026, up 116.67% year-over-year from $12.0 million in Q1 2025, and up 1200.0% quarter-over-quarter from $2.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Current Taxes history runs 6 years deep, the most recent figure standing at $26.0 million for Q1 2026.
- In Q1 2026, Current Taxes rose 116.67% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $26.0 million (up 116.67% YoY), while the FY2025 annual figure was $2.0 million, down 71.43% from the prior year.
- Current Taxes for Q1 2026 stood at $26.0 million, up from $2.0 million in the prior quarter.
- The five-year high for Current Taxes was $26.0 million in Q1 2026, with the low at $2.0 million in Q4 2025.
- The 5-year median for Current Taxes is $8.5 million (2022), against an average of $10.6 million.
- The sharpest annual moves came in 2025 and 2026: Current Taxes tumbled 71.43% in 2025, then soared 116.67% in 2026.
- Indivior Pharmaceuticals' Current Taxes stood at $9.0 million in 2022, then retreated by 11.11% to $8.0 million in 2023, then retreated by 12.5% to $7.0 million in 2024, then sank by 71.43% to $2.0 million in 2025, then soared by 1200.0% to $26.0 million in 2026.
- Business Quant data shows INDV's Current Taxes at $26.0 million in Q1 2026, $2.0 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 46.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.56 Bn | 4.34 Bn | 294.00 Mn | 30.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.00 Mn |
| Mar 31, 2026 | 26.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 7.00 Mn |